Investment Rating - The report maintains a "Buy" rating for Dingzhi Technology [1] Core Views - The company's revenue and profit were under pressure in H1 2024, primarily due to a sharp decline in demand for downstream medical equipment, resulting in a revenue drop of 47.20% year-on-year to 103 million yuan and a net profit decline of 68.55% to 17 million yuan [2] - Despite the short-term challenges, the report highlights the broad growth potential in the robotics business, supported by ongoing investments in R&D and international expansion [2][3] Financial Performance Summary - **Revenue and Profit Forecasts**: - Total revenue for 2024 is projected at 165 million yuan, down from 282 million yuan in 2023, with a further increase to 187 million yuan in 2025 and 205 million yuan in 2026 [1][8] - Net profit attributable to shareholders is expected to decline to 53 million yuan in 2024, with projections of 61 million yuan in 2025 and 68 million yuan in 2026 [1][8] - **Earnings Per Share (EPS)**: - The latest diluted EPS is forecasted to be 0.39 yuan in 2024, increasing to 0.46 yuan in 2025 and 0.50 yuan in 2026 [1][8] - **Valuation Metrics**: - The current price-to-earnings (P/E) ratios are projected at 37.92 for 2024, 32.60 for 2025, and 29.54 for 2026 [1][8] Product and Market Insights - **Product Performance**: - In H1 2024, the revenue from hybrid stepper motors was 20 million yuan (down 32.83%), linear actuators 63 million yuan (down 17.17%), and voice coil motors 3 million yuan (down 95.72%) [2] - **Gross Margin Trends**: - The gross margin improved to 53.60%, up 2.18 percentage points year-on-year, primarily due to a shift in product mix as lower-margin products saw reduced sales [2] - **Overseas Expansion**: - The company is investing in overseas business development, including a 3 million yuan investment in Weier Intelligent Control Systems to enhance innovation and expand sales channels [2] - **Robotics Business Outlook**: - The partnership with AIDIN Robotics and recognition as a valuable player in the humanoid robotics sector indicate significant future growth potential [2]

证券代码：873593 证券简称：鼎智科技 公告编号：2024-064 江苏鼎智智能控制科技股份有限公司 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 一、募集资金情况概述 2023 年 3 月 10 日，公司收到中国证券监督管理委员会《关于同意江苏鼎智 智能控制科技股份有限公司向不特定合格投资者公开发行股票注册的批复》（证 监许可【2023】539 号），同意公司向不特定合格投资者公开发行股票的注册申 请。 公司向不特定合格投资者公开发行普通股股票 11,572,000 股（不含超额配 售选择权），每股发行价格为人民币 30.60 元，募集资金总额为人民币 354,103,200.00 元，扣除发行费用人民币 38,976,608.46 元（不含税），募集资 金净额为人民币 315,126,591.54 元。上述募集资金已于 2023 年 4 月 3 日全部到 位，并经天健会计师事务所（特殊普通合伙）审验并出具了天健验〔2023〕15-2 号验资报告。 公司行使超额配售选择权定向增发人民币普通股股票 ...

证券代码：873593 证券简称：鼎智科技 公告编号：2024-063 江苏鼎智智能控制科技股份有限公司 第二届董事会第八次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2024 年 8 月 29 日 2.会议召开地点：鼎智科技三楼会议室一 3.会议召开方式：现场 4.发出董事会会议通知的时间和方式：2024 年 8 月 24 日以书面方式发出 5.会议主持人：董事长华荣伟先生 6.会议列席人员：董事会秘书朱国华 7.召开情况合法、合规、合章程性说明： 本次会议的出席人数、召集、召开方式、议案审议程序等均符合《中华人民 共和国公司法》等法律法规和《公司章程》的规定。 （二）会议出席情况 会议应出席董事 7 人，出席和授权出席董事 7 人。 二、议案审议情况 （一）审议通过《关于公司 2024 年半年度报告及摘要的议案》 1.议案内容： 具体内容详见公司于 2024 年 8 月 29 日在北京证券交易所官方信息披露平台 (www ...

证券代码：873593 证券简称：鼎智科技 公告编号：2024-062 江苏鼎智智能控制科技股份有限公司 2024 年半年度募集资金存放与实际使用情况的专项报告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、募集资金基本情况 （一）、北京证券交易所向不特定合格投资者公开发行股票募集资金 2023 年 3 月 10 日，公司收到中国证券监督管理委员会《关于同意江苏鼎智 智能控制科技股份有限公司向不特定合格投资者公开发行股票注册的批复》（证 监许可【2023】539 号），同意公司向不特定合格投资者公开发行股票的注册申 请。 公司向不特定合格投资者公开发行普通股股票 11,572,000 股（不含超额配 售选择权），每股发行价格为人民币 30.60 元，募集资金总额为人民币 354,103,200.00 元，扣除发行费用人民币 38,976,608.46 元（不含税），募集资 金净额为人民币 315,126,591.54 元。上述募集资金已于 2023 年 4 月 3 日全部到 位，并经天健会计师事务 ...

第二届监事会第七次会议决议公告 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 本次会议的出席人数、召集、召开方式、议案审议程序等均符合《中华人民 共和国公司法》等法律法规和《公司章程》的规定。 （二）会议出席情况 会议应出席监事 3 人，出席和授权出席监事 3 人。 证券代码：873593 证券简称：鼎智科技 公告编号：2024-059 江苏鼎智智能控制科技股份有限公司 （一）审议通过《关于公司 2024 年半年度报告及摘要的议案》 1.议案内容： 具体内容详见公司于 2024 年 8 月 29 日在北京证券交易所官方信息披露平台 (www.bse.cn)上披露的公司《2024 年半年度报告》（公告编号：2024-060）、《2024 1.会议召开时间：2024 年 8 月 29 日 2.会议召开地点：鼎智科技三楼会议室一 3.会议召开方式：现场 4.发出监事会会议通知的时间和方式：2024 年 8 月 24 日 以书面方式发出 5.会议主持人：监事会主席程 ...

Financial Performance - The company's operating revenue for the first half of 2024 was ¥102,938,718.85, a decrease of 47.20% compared to ¥194,970,750.78 in the same period last year[13]. - The net profit attributable to shareholders of the listed company was ¥17,056,132.14, down 68.55% from ¥54,226,331.53 in the previous year[13]. - The basic earnings per share decreased by 81.43% to ¥0.13 from ¥0.70 in the same period last year[13]. - Operating revenue declined by 47.20% year-on-year, indicating a challenging market environment[17]. - Net profit decreased by 69.70%, reflecting significant operational difficulties[17]. - The company reported a net profit margin decline due to increased operational costs and reduced revenue, impacting overall profitability[70]. - The company's net profit for the first half of 2024 was CNY 23,803,932.74, a decrease from CNY 50,874,977.87 in the same period of 2023, representing a decline of approximately 53.2%[72]. - The total profit for the first half of 2024 was CNY 26,438,105.69, down from CNY 58,213,120.22 in the same period of 2023, a decrease of around 54.5%[72]. Revenue and Sales - Total revenue for the company was 102,938,718.85 CNY, a decrease of 58.40% in domestic sales compared to the same period last year[36][38]. - The revenue from hybrid stepper motors decreased by 32.83% year-over-year, primarily due to market fluctuations in the industrial control sector[38]. - Linear actuators saw a revenue decline of 17.17% year-over-year, attributed to temporary market impacts in the medical device industry[38]. - The company reported a significant drop in revenue from voice coil motors, down 95.72% year-over-year, due to the previous year's surge in demand for medical ventilators[38]. - The revenue from domestic operations is $59,850,576.59, a significant decrease from $143,861,358.27 in the same period last year[153]. - The revenue from overseas operations is $43,088,142.26, compared to $51,109,392.51 in the same period last year, reflecting a decline of 15.7%[153]. Assets and Liabilities - Total assets increased by 0.54% to ¥719,791,479.74 compared to the previous year[14]. - Total liabilities rose significantly by 49.24% to ¥71,933,809.83, impacting the debt-to-asset ratio which increased to 9.99%[14]. - The company's total assets as of June 30, 2024, amounted to CNY 715,594,915.35, compared to CNY 706,119,499.16 at the end of 2023, reflecting a slight increase of approximately 1.7%[68]. - Total liabilities increased to CNY 67,207,183.58 in the first half of 2024 from CNY 43,141,755.45 in the same period of 2023, marking an increase of about 55.8%[69]. - The company's equity attributable to shareholders decreased to CNY 648,387,731.77 as of June 30, 2024, down from CNY 662,977,743.71 at the end of 2023, a decline of approximately 2.2%[69]. Research and Development - The company completed the R&D of a high-frequency breathing module for infant ventilators, significantly improving reliability and operational lifespan[24]. - The company has established a comprehensive R&D process focused on both independent and collaborative development to enhance product performance and expand its technology portfolio[21]. - Research and development expenses for the current period amount to $16,730,808.56, an increase of 13.9% from $14,678,998.14 in the same period last year[155]. - The company incurred research and development expenses of CNY 11,100,186.55 in the first half of 2024, slightly down from CNY 11,110,080.09 in the first half of 2023[72]. Market Strategy and Partnerships - The company maintains a "make-to-order" production model, allowing flexibility in production based on customer demand[20]. - The sales strategy includes direct sales and distribution, targeting both domestic and international markets, with a focus on regions such as South China and East China[20]. - The company entered into a strategic partnership with AIDIN Robotics to distribute advanced sensor products in China, enhancing its market presence[25]. - The company is focused on optimizing and innovating its core competencies in micro-motors for medical and industrial automation sectors, while also accelerating its entry into new fields within humanoid robotics[27]. Financial Management - The report was not audited by an accounting firm, and the management guarantees the accuracy and completeness of the financial data[3]. - The company has not faced any delisting risks as per the report[5]. - The company has established a proactive approach to manage inventory levels in response to potential declines in demand for ventilators and testing products[3]. - The company has set aside provisions for inventory depreciation due to prolonged inventory turnover times, indicating a cautious approach to market fluctuations[3]. - The company has recognized a need for talent development and innovation, establishing a dual-channel development mechanism and enhancing academic exchanges to foster employee R&D capabilities[3]. Shareholder Information - The total share capital increased from 96,044,078 shares to 134,461,709 shares due to a stock dividend distribution[56]. - The company’s major shareholders include Jiangsu Leili Electric Co., Ltd. with a 34.53% stake and Ding Quanjun with a 17.92% stake[57]. - The company plans to distribute a cash dividend of RMB 4 per share (including tax), totaling RMB 38,417,631.20, based on a total share capital of 96,044,078 shares[87]. Risk Management - The company is facing risks related to the potential loss of technical personnel, which could impact its innovation capabilities and competitive advantage[44]. - The company has faced risks related to raw material price fluctuations, particularly for motors, stator components, and lead screws, which are closely tied to copper and steel prices[3]. - The company has established risk management strategies to balance risk and return, focusing on minimizing negative impacts on performance[178]. - The company’s liquidity risk management includes a combination of short-term and long-term financing to maintain flexibility[180]. Compliance and Governance - The company adheres to the accounting standards and principles, ensuring that the financial statements accurately reflect its financial position and performance[89]. - The company has not engaged in any strategic investments or directed offerings during the reporting period[59]. - The board of directors consists of 7 members, while the supervisory board has 3 members[61].

证券代码：873593 证券简称：鼎智科技 公告编号：2024-059 江苏鼎智智能控制科技股份有限公司 第二届监事会第七次会议决议公告 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 本次会议的出席人数、召集、召开方式、议案审议程序等均符合《中华人民 共和国公司法》等法律法规和《公司章程》的规定。 （二）会议出席情况 会议应出席监事 3 人，出席和授权出席监事 3 人。 二、议案审议情况 具体内容详见公司于 2024 年 8 月 29 日在北京证券交易所官方信息披露平台 (www.bse.cn)上披露的公司《2024 年半年度募集资金存放与实际使用情况的专 项报告》（公告编号：2024-062） 具体内容详见公司于 2024 年 8 月 29 日在北京证券交易所官方信息披露平台 (www.bse.cn)上披露的公司《2024 年半年度报告》（公告编号：2024-060）、《2024 1.会议召开时间：2024 年 8 月 29 日 2.会议召开地点：鼎智科技 ...

证券代码：873593 证券简称：鼎智科技 公告编号：2024-062 江苏鼎智智能控制科技股份有限公司 2024 年半年度募集资金存放与实际使用情况的专项报告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 2023 年 3 月 10 日，公司收到中国证券监督管理委员会《关于同意江苏鼎智 智能控制科技股份有限公司向不特定合格投资者公开发行股票注册的批复》（证 监许可【2023】539 号），同意公司向不特定合格投资者公开发行股票的注册申 请。 公司向不特定合格投资者公开发行普通股股票 11,572,000 股（不含超额配 售选择权），每股发行价格为人民币 30.60 元，募集资金总额为人民币 354,103,200.00 元，扣除发行费用人民币 38,976,608.46 元（不含税），募集资 金净额为人民币 315,126,591.54 元。上述募集资金已于 2023 年 4 月 3 日全部到 位，并经天健会计师事务所（特殊普通合伙）审验并出具了天健验〔2023〕15-2 号验资报告。 公司行使超额 ...

江苏鼎智智能控制科技股份有限公司 证券代码：873593 证券简称：鼎智科技 公告编号：2024-063 第二届董事会第八次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2024 年 8 月 29 日 2.会议召开地点：鼎智科技三楼会议室一 3.会议召开方式：现场 4.发出董事会会议通知的时间和方式：2024 年 8 月 24 日以书面方式发出 5.会议主持人：董事长华荣伟先生 6.会议列席人员：董事会秘书朱国华 7.召开情况合法、合规、合章程性说明： 本次会议的出席人数、召集、召开方式、议案审议程序等均符合《中华人民 共和国公司法》等法律法规和《公司章程》的规定。 （二）会议出席情况 会议应出席董事 7 人，出席和授权出席董事 7 人。 二、议案审议情况 （一）审议通过《关于公司 2024 年半年度报告及摘要的议案》 1.议案内容： 具体内容详见公司于 2024 年 8 月 29 日在北京证券交易所官方信息披露平台 (www ...

证券代码：873593 证券简称：鼎智科技 公告编号：2024-058 江苏鼎智智能控制科技股份有限公司股票解除限售公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、本次股票解除限售数量总额为 57,788,201 股，占公司总股本 42.98%，可交 易时间为 2024 年 9 月 3 日。 二、本次股票解除限售的明细情况及原因 单位：股 | | 合计 | — | 57,788,201 | 42.98% | 19,025,797 | | --- | --- | --- | --- | --- | --- | | | 注：解除限售原因： | | | | | | A | 董事、监事、高级管理人员每年解除限售 | | | | | | B | 离职董事、监事、高级管理人员解除限售 | | | | | C 自愿限售解除限售 D 限制性股票解除限售 E 公开发行前特定主体股票解除限售上市 F 参与战略配售取得股票解除限售上市 G 其他（说明具体原因） 自愿限售解除情况说明 公司现根据《上市规则》、《上市业 ...